Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

The World Bank's Board of Executive Directors has approved a €544 million Development Policy Loan to support Romania's efforts to restore fiscal sustainability, enable private sector-led growth and foster job creation.
Etem Gestamp, the Sofia-based joint venture between Viohalco Group and Spain's Gestamp Group, has signed a 10-year virtual power purchase agreement (VPPA) with Rezolv Energy, the Actis-backed independent power producer.
Raiffeisen Bank has reached an agreement to acquire 100% of the shares in Garanti BBVA Group Romania, including Garanti Bank and leasing unit Motoractive IFN, from subsidiaries of Banco Bilbao Vizcaya Argentaria.
JTI announced a €300 million investment to build a new factory in Ștefăneștii de Jos, Ilfov County.
Parapet, an EPC contractor in the renewable energy sector, has appointed Roxana Gureanu as CEO, as the company experiences rapid growth and international expansion.